Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
04/2009
04/09/2009WO2009044160A1 Pyridine derivatives for the treatment of amyloid-related diseases
04/09/2009WO2009043784A1 Cyclopropyl aryl amide derivatives and uses thereof
04/09/2009WO2009043773A1 Biocidal mixtures
04/09/2009WO2009043582A1 Nicotinamide n-oxide derivatives as vanilloid-1 receptor modulators
04/09/2009WO2009043117A1 Novel aryl potassium channel blockers and uses thereof
04/09/2009WO2008074997A8 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors
04/09/2009WO2008050168A8 New sulfonamide derivatives as bradykinin antagonists
04/09/2009WO2005005382A3 Compounds, compositions and methods
04/09/2009US20090093664 Carbon nanotubes using for recovery of radionuclides and separation of actinides and lanthanides
04/09/2009US20090093638 Allylic Oxidations Catalyzed by Dirhodium Catalysts under Aqueous Conditions
04/09/2009US20090093541 Melanin eliminator preparation
04/09/2009US20090093526 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
04/09/2009US20090093525 N-(1,1-dialkyl-2-arylcyclopropyl)arylcarboxamides, e.g., Chloro-N-[cis-2,2-dimethyl-3-(4-sulfamoyl-phenyl)-cyclopropyl]-2-methoxy-benzamide; nicotinic acetylcholine receptor ligands, particularly positive allosteric modulators for the alpha 7 nAChR subtype
04/09/2009US20090093485 Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases
04/09/2009US20090093484 Novel compounds, their preparation and use
04/09/2009US20090093483 enzyme inhibitor for treating ischemia, anemia, wound healing, auto-transplantation, allo-transplantation, xeno-transplantation, systemic high blood pressure, thalassemia, diabetes, cancer, and inflammatory disorders; N-((4-hydroxy-2-oxo-6-(trifluoromethyl)-2',3',5',6'-tetrahydro-2H-spiro[naphthalene-1,4
04/09/2009US20090093462 3-Arylamino pyridine derivatives
04/09/2009US20090093416 Caspase inhibitors and uses thereof
04/09/2009CA2701579A1 Novel aryl potassium channel blockers and uses thereof
04/09/2009CA2701115A1 N-hydroxy-naphthalene dicarboxamide and n-hydroxy-biphenyl-dicarboxamide compounds as histone deacetylase inhibitors
04/09/2009CA2701020A1 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
04/09/2009CA2700857A1 Hdac inhibitors
04/09/2009CA2700762A1 Pyridine derivatives for the treatment of amyloid-related diseases
04/09/2009CA2699625A1 Cyclopropyl aryl amide derivatives and uses thereof
04/09/2009CA2699598A1 2-substituted-6-amino-5-alkyl, alkenyl or alkynyl-4-pyrimidinecarboxylic acids and 6-substituted-4-amino-3-alkyl, alkenyl or alkynyl picolinic acids and their use as herbicides
04/08/2009EP2044024A1 New pyridine analogues
04/08/2009EP2044023A1 Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors
04/08/2009EP2044006A1 Insecticidal compounds
04/08/2009EP2044005A2 Prolyl hydroxylase inhibitors and methods of use
04/08/2009EP2044004A2 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity
04/08/2009EP2043993A2 Cyclopentane derivatives as antiglaucoma agents
04/08/2009EP1877364B1 Phenylacetylene derivatives having mglur5 receptor affinity
04/08/2009EP1863933A4 Dimeric and trimeric nucleic acid dyes, and associated systems and methods
04/08/2009EP1831198B1 Pyridine carboxamide derivatives for use as anticancer agents
04/08/2009EP1430023B1 Substituied urea retinoid agonists ii
04/08/2009CN101405268A Amide derivatives and their application for the treatment of g protein related diseases
04/08/2009CN101405267A Process for preparing l-halo-2,7-naphthyridinyl derivatives
04/08/2009CN101405266A Piperazines and piperidines as mGlur5 potentiators
04/08/2009CN101405264A Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
04/08/2009CN101402600A Process for producing vitamin B6
04/08/2009CN101402554A 2- and 2,5-substituted phenylketo-enols
04/08/2009CN100475791C Method for preparing 6-hydroxyl-3-cyanogen pyridine
04/08/2009CN100475790C Pyridyloxyalkanoic acid amide derivatives useful as fungicides
04/08/2009CN100475787C Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
04/08/2009CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/08/2009CN100475777C Amide type carboxamide derivative
04/07/2009US7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
04/07/2009US7514582 Cardiac ANTIARRHYTHMIA AGENTS; atrial fibrillation or atrial flutter; Kv1.5 potassium channel blockers;
04/07/2009US7514565 3,5-Difluoropyridines
04/07/2009US7514559 Catalyst for synthesis of 2- and 4-picolines
04/07/2009US7514555 Compounds for the treatment of metabolic disorders
04/07/2009US7514475 Benzylamine analogues
04/07/2009US7514456 Nicotinamide derivatives useful as p38 inhibitors
04/07/2009US7514455 Derivatives of 2-pyridinol or its tautomer 2-pyridone; microorganism comprising Penicillium sp. FO-125 FERM BP-8048; antifungal antibiotics
04/07/2009US7514449 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects
04/07/2009US7514445 Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors)
04/07/2009US7514436 Antidiabetic agents; disease of glucose tolerance; insulin resistance; obesity; dyslipidemia; metabolic disorders; liver disorders; [4-(6-Phenethyloxy-pyridazin-3-yl)piperazin-1-yl]-(2-trifluoromethyl-phenyl)-methanone; stearoyl-CoA desaturase modulators
04/07/2009CA2415890C N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
04/07/2009CA2362833C Phenylalaninol derivatives
04/07/2009CA2278851C 2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamides with carboxylic acid derivatives on the pyridine ring
04/07/2009CA2276278C Amine compounds, their production and use
04/07/2009CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease
04/02/2009WO2009041475A1 Method for producing pyrazol-3-yl-benzamide derivative
04/02/2009WO2009040551A1 Luminophores
04/02/2009WO2009040288A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
04/02/2009WO2009039635A1 Methods of modulating neurotrophin-mediated activity
04/02/2009WO2008104994A3 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
04/02/2009US20090088574 Crystal of 1,2-dihydropyridine compound (type iv)
04/02/2009US20090088570 Organic electroluminescent device
04/02/2009US20090088459 Novel biaryl sulfonamide derivatives
04/02/2009US20090088458 N-(Pyridin-4-Yl)-2-Phenylbutanamides as Androgen Receptor Modulators
04/02/2009US20090088457 Primary Amines as Renin Inhibitors
04/02/2009US20090088456 2-Pyridinylethylcarboxamide derivatives and their use as Fugicides
04/02/2009US20090088419 Pyridyl acetic acid compounds
04/02/2009US20090088322 e.g.4-Amino-6-(4-chlorophenyl)-5-fluoro-3-vinylpyridine-2-carboxylic acid; 4-Acetylamino-6-(4-chloro-2-fluoro-3-methoxyphenyl)-3-trimethylsilanylethynylpyridine-2-carboxylic acid methyl ester;
04/02/2009US20090085006 Activators for oligonucleotide synthesis
04/02/2009CA2700936A1 Production method for pyrazol-3-yl-benzamide derivative
04/02/2009CA2700277A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
04/01/2009EP2042489A1 Removal and prevention of discolouration of pyrithione-containing materials
04/01/2009EP2042478A1 Method for producing -diaryl electron-withdrawing group substituted compound
04/01/2009EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases
04/01/2009EP2041111A1 New pyridine analogues
04/01/2009EP2041093A1 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
04/01/2009EP2041092A1 N- [ (pyridin- 2 -yl) methoxy]heterocyclyl carboxamide derivatives and related compounds as fungicides
04/01/2009EP2041091A1 N-[(pyridin-2-yl) methoxy]benzamide derivatives and related compounds as fungicides
04/01/2009EP2041090A1 N- (4-pyridin-2-ylbutyl) benzamide derivatives and their use as fungicides
04/01/2009EP2041089A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds
04/01/2009EP2041088A1 Glycine transporter-1 inhibitors
04/01/2009EP2041087A1 2 -oxybenzamide derivatives as parp inhibitors
04/01/2009EP2041072A1 Cxcr2 antagonists
04/01/2009EP2041071A2 Biaryl compositions and methods for modulating a kinase cascade
04/01/2009EP2040688A1 New cxcr2 inhibitors
04/01/2009EP1907360A4 Improved process for the manufacture of flecainide
04/01/2009EP1660431B1 Phenoxyacetic acid derivatives
04/01/2009EP1646661B1 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drung obtained therefrom
04/01/2009EP1611102A4 Using alkylmetal reagents for directed metalation of azaaromatics
04/01/2009EP1082308B1 Heterocyclically substituted amides used as calpain inhibitors
04/01/2009CN101400654A 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors
04/01/2009CN101397271A Method for preparing vitamin B6
03/2009
03/31/2009US7511151 2-(5-chloropyridyl-3-oxy)-2-(ethoxy)-N-(2-methylpent-3-yn-2-yl) acetamide; preferably used for agricultural, horticultural and turfgrass purposes to control phytopathogenic fungi